Please use this identifier to cite or link to this item:
https://ir.swu.ac.th/jspui/handle/123456789/13086
Title: | Aromatase inhibitory activity of 1,4-naphthoquinone derivatives and QSAR study |
Authors: | Prachayasittikul V. Pingaew R. Worachartcheewan A. Sitthimonchai S. Nantasenamat C. Prachayasittikul S. Ruchirawat S. Prachayasittikul V. |
Keywords: | 1,4 naphthoquinone derivative 2 amino(chloro) 3 chloro 1,4 naphthoquinone derivative compound 1 compound 10 compound 11 compound 2 compound 3 compound 4 compound 5 compound 6 compound 7 compound 8 compound 9 doxorubicin ketoconazole letrozole unclassified drug Article computer model controlled study cytotoxicity drug determination drug structure drug synthesis human human cell IC50 quantitative structure activity relation |
Issue Date: | 2017 |
Abstract: | A series of 2-amino(chloro)-3-chloro-1,4-naphthoquinone derivatives (1-11) were investigated for their aromatase inhibitory activities. 1,4-Naphthoquinones 1 and 4 were found to be the most potent compounds affording IC50 values 5.2 times lower than the reference drug, ketoconazole. A quantitative structure-activity relationship (QSAR) model provided good predictive performance (R2 CV = 0.9783 and RMSECV = 0.0748) and indicated mass (Mor04m and H8m), electronegativity (Mor08e), van der Waals volume (G1v) and structural information content index (SIC2) descriptors as key descriptors governing the activity. To investigate the effects of structural modifications on aromatase inhibitory activity, the model was employed to predict the activities of an additional set of 39 structurally modified compounds constructed in silico. The prediction suggested that the 2,3-disubstitution of 1,4-naphthoquinone ring with halogen atoms (i.e., Br, I and F) is the most effective modification for potent activity (1a, 1b and 1c). Importantly, compound 1b was predicted to be more potent than its parent compound 1 (11.90-fold) and the reference drug, letrozole (1.03-fold). The study suggests the 1,4-naphthoquinone derivatives as promising compounds to be further developed as a novel class of aromatase inhibitors. © 2017, Leibniz Research Centre for Working Environment and Human Factors. All rights reserved. |
URI: | https://ir.swu.ac.th/jspui/handle/123456789/13086 https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019633218&doi=10.17179%2fexcli2017-309&partnerID=40&md5=6eeb41e54bf47070f70cf31e8a3adb75 |
ISSN: | 16112156 |
Appears in Collections: | Scopus 1983-2021 |
Files in This Item:
There are no files associated with this item.
Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.